Neurocrine Biosciences | NBIX - PE价格收益



金融业
股票价格
USD
资产
USD 5.36B
现金及等价物
USD 332.4M
销售成本
USD 39.4M
流动资产
USD 1.64B
流动负债
USD 874.5M
债务
USD 406.2M
EBIT
USD 219.9M
EBITDA
USD 193.3M
员工
1.8K
EPS每股收益
USD 2.85
股本和储备
USD 3.69B
销售毛利
USD 800.7M
债务利息支出
USD 1.1M
贷款资金
USD 169.5M
市值
USD 15.62B
净收入
USD 144.4M
营业费用
USD 739.1M
营业利润
USD 219.9M
普通股股本
USD 100.55M
PE价格收益
22.1
税前利润
USD 246.8M
销售收入
USD 959M
销售和管理费用
USD 383.1M
股票
USD 104.2M
贸易债权人
USD 691.3M
应收帐款人
USD 887M


Pe 更改 日
AbbVie 23.96 0.93 2026-06
Acadia Pharmaceuticals 11.33 1.25 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
ALKERMES 135.81 96.48 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Exelixis 18.02 4.11 2026-06
Gilead Sciences 13.51 4.2 2026-06
Halozyme Therapeutics 12.51 1.15 2026-06
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 22.1 5.99 2026-06
Pfizer 11.48 2.16 2026-06
Prothena 22.11 11.37 2022-03
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Repligen 105.09 4.39 2026-06
Rigel Pharmaceuticals 8.61 8.4 2025-03
Sarepta Therapeutics 27.27 0 2026-03
Teva Pharmaceutical Industries 24.6 14.53 2026-06
Vertex Pharmaceuticals 28.05 2.22 2026-06